Brookline, MA, United States of America

Naomi Choodnovskiy

This inventor holds 1 USPTO granted patent. Top assignee: Smartcells, Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naomi Choodnovskiy. Retrieved from https://idiyas.com/inventor/naomi-choodnovskiy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Celebrating the Innovations of Naomi Choodnovskiy

Introduction: Naomi Choodnovskiy is a remarkable inventor based in Brookline, Massachusetts, whose contributions to the field of biotechnology are noteworthy. With her innovative approach, she has successfully developed groundbreaking technologies that harness the power of lectins. Her work is particularly significant in the context of glucose detection and release mechanisms.

Latest Patents: Choodnovskiy holds a patent for "Recombinant lectins, binding-site modified lectins and uses thereof." This patent introduces cross-linked materials that feature multivalent lectins with multiple binding sites for glucose. The technology includes affinity ligands capable of competing with glucose for binding, covalently linked to cysteine residues of the lectins. These conjugates are designed to release amounts of conjugate in response to specific concentrations of glucose, which can be advantageous in various applications, including drug delivery and diagnostic labeling.

Career Highlights: Choodnovskiy’s career is marked by her position at Smartcells, Inc., where she has been instrumental in advancing research and development in the field of biomedicine. Her innovative solutions reflect her dedication to enhancing healthcare through scientific discovery.

Collaborations: Throughout her career, Naomi has collaborated with esteemed colleagues, including Thomas M. Lancaster and Robert Butters. These partnerships have allowed for the pooling of expertise and resources, further driving the development of her patented technologies and contributing to the company's vision.

Conclusion: Naomi Choodnovskiy exemplifies the innovative spirit that fuels advancements in biotechnology. With her patented work on recombinant lectins, she is making significant strides in glucose detection and therapeutic applications, paving the way for future innovations in health and medicine. Her contributions not only enhance scientific knowledge but also hold the promise of improving patient outcomes in various medical fields.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…